Harrow, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
HROW Nasdaq 2834 www.harrow.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Harrow, Inc.

Discover 3 Elite Growth Stocks With Significant Insider Ownership - Dec 22nd, 2025 10:35 am
Eye Drops Maker Sets Up After Strategic Buy; Sales Outlook Strong - Dec 9th, 2025 10:56 am
How the Narrative Surrounding Harrow Is Evolving After Analyst Target Upgrades - Dec 6th, 2025 7:05 am
How CVS Elevating Vevye To Tier 1 Coverage At Harrow (HROW) Has Changed Its Investment Story - Dec 3rd, 2025 8:11 am
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% - Nov 27th, 2025 9:39 am
A Fresh Look at Harrow (HROW) Valuation Following Recent Revenue Growth and Long-Term Performance - Nov 25th, 2025 6:12 pm
Harrow to Present at Two Investor Conferences in December - Nov 24th, 2025 5:00 am
Harrow Announces Closing of Acquisition of Melt Pharmaceuticals - Nov 18th, 2025 5:00 am
Private Capital's Strategic Moves: Spotlight on Matthews International Corp - Nov 14th, 2025 3:03 pm
Harrow Inc (HROW) Q3 2025 Earnings Call Highlights: Revenue Surge and Strategic Growth Plans - Nov 11th, 2025 12:01 pm
Assessing Harrow (HROW) Valuation Following Strong Q3 Growth and New Product Momentum - Nov 10th, 2025 11:09 pm
Harrow (HROW) Is Up After Q3 Profit Turnaround and Revenue Growth Are Reported – What's Changed - Nov 10th, 2025 8:15 pm
Harrow: Q3 Earnings Snapshot - Nov 10th, 2025 2:31 pm
Harrow Announces Third Quarter 2025 Financial Results - Nov 10th, 2025 2:05 pm
Harrow To Report Third Quarter 2025 Financial Results After Market Close on November 10, 2025 - Oct 27th, 2025 5:00 am
Harrow, Inc. (HROW): A Bull Case Theory - Oct 8th, 2025 9:23 am
Could Harrow’s (HROW) New Pricing Program Redefine Its Patient Access Advantage? - Oct 7th, 2025 7:24 am
ImprimisRx Announces Leadership Changes - Oct 6th, 2025 5:00 am
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever? - Sep 26th, 2025 6:57 am
Harrow to Acquire Melt Pharmaceuticals - Sep 26th, 2025 5:00 am